Insys Therapeutics, Inc. Operating Income
Insys Therapeutics, Inc. reported Operating Income of -$122.11 million for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-13.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2019-05-13
- Insys Therapeutics, Inc. operating income (loss) for the quarter ending 2019-03-31 was -$122.11M.
- Insys Therapeutics, Inc. operating income (loss) for the quarter ending 2018-12-31 was -$48.97M.
- Insys Therapeutics, Inc. operating income (loss) for the quarter ending 2018-09-30 was -$30.82M.
- Insys Therapeutics, Inc. operating income (loss) for the quarter ending 2018-06-30 was -$27.70M.
- Insys Therapeutics, Inc. operating income (loss) for fiscal 2018 was -$127.72M.
- Insys Therapeutics, Inc. operating income (loss) for fiscal 2017 was -$219.03M, a 3089.78% decline from fiscal 2016.
- Insys Therapeutics, Inc. operating income (loss) for fiscal 2016 was $7.33M, a 91.90% decline from fiscal 2015.
- Insys Therapeutics, Inc. operating income (loss) for fiscal 2015 was $90.46M, a 48.31% increase from fiscal 2014.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2019-03-31 | -$122.11M 10-Q · filed 2019-05-13 | -$171.08M derived: sum of 2 quarters · filed 2019-05-13 | -$201.90M derived: sum of 3 quarters · filed 2019-05-13 | -$229.60M derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2018-12-31 | -$48.97M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | -$79.78M derived: sum of 2 quarters · filed 2019-03-13 | -$107.49M derived: sum of 3 quarters · filed 2019-03-13 | -$127.72M 10-K · filed 2019-03-13 | ||||
| 2018-09-30 | -$30.82M 10-Q · filed 2018-11-09 | -$58.52M derived: sum of 2 quarters · filed 2018-11-09 | -$78.76M 10-Q · filed 2018-11-09 | -$99.42M derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2018-06-30 | -$27.70M 10-Q · filed 2018-08-09 | -$47.94M 10-Q · filed 2018-08-09 | -$68.60M derived: sum of 3 quarters · filed 2019-05-13 | -$244.34M derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2018-03-31 | -$20.23M 10-Q · filed 2019-05-13 | -$40.89M derived: sum of 2 quarters · filed 2019-05-13 | -$216.64M derived: sum of 3 quarters · filed 2019-05-13 | -$226.95M derived: sum of 4 quarters · filed 2019-05-13 | ||||
| 2017-12-31 | -$20.66M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | -$196.40M derived: sum of 2 quarters · filed 2019-03-13 | -$206.72M derived: sum of 3 quarters · filed 2019-03-13 | -$219.03M 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | -$175.74M 10-Q · filed 2018-11-09 | -$186.06M derived: sum of 2 quarters · filed 2018-11-09 | -$198.37M 10-Q · filed 2018-11-09 | -$202.00M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-06-30 | -$10.32M 10-Q · filed 2018-08-09 | -$22.63M 10-Q · filed 2018-08-09 | -$26.26M derived: sum of 3 quarters · filed 2019-03-13 | -$24.00M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2017-03-31 | -$12.31M 10-Q · filed 2018-05-10 | -$15.94M derived: sum of 2 quarters · filed 2019-03-13 | -$13.68M derived: sum of 3 quarters · filed 2019-03-13 | -$7.24M derived: sum of 4 quarters · filed 2019-03-13 | ||||
| 2016-12-31 | -$3.63M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | -$1.37M derived: sum of 2 quarters · filed 2019-03-13 | $5.08M derived: sum of 3 quarters · filed 2019-03-13 | $7.33M 10-K · filed 2019-03-13 | ||||
| 2016-09-30 | $2.27M 10-Q · filed 2017-11-03 | -$328.00K 10-Q · filed 2016-11-03 | $8.71M derived: sum of 2 quarters · filed 2017-11-03 | $10.96M 10-Q · filed 2017-11-03 | $6.31M 10-Q · filed 2016-11-03 | $41.96M derived: sum of 4 quarters · filed 2018-03-12 | ||
| 2016-06-30 | $6.44M 10-Q · filed 2017-08-07 | $4.34M 10-Q · filed 2016-08-05 | $8.69M 10-Q · filed 2017-08-07 | $6.63M 10-Q · filed 2016-08-05 | $39.69M derived: sum of 3 quarters · filed 2018-03-12 | $76.07M derived: sum of 4 quarters · filed 2018-03-12 | ||
| 2016-03-31 | $2.25M 10-Q · filed 2017-05-09 | $2.29M 10-Q · filed 2016-05-05 | $33.25M derived: sum of 2 quarters · filed 2018-03-12 | $69.63M derived: sum of 3 quarters · filed 2018-03-12 | $84.15M derived: sum of 4 quarters · filed 2018-03-12 | |||
| 2015-12-31 | $31.00M derived: 10-K 12 month − 10-Q/A 9 month · filed 2018-03-12 | $67.38M derived: sum of 2 quarters · filed 2018-03-12 | $81.90M derived: sum of 3 quarters · filed 2018-03-12 | $90.46M 10-K · filed 2018-03-12 | $92.43M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $39.12M 10-Q · filed 2016-11-03 | $50.90M derived: sum of 2 quarters · filed 2017-04-07 | $59.46M 10-Q/A · filed 2017-04-07 | $62.71M 10-Q · filed 2015-11-05 | $72.57M derived: sum of 4 quarters · filed 2017-04-07 | |||
| 2015-06-30 | $14.53M 10-Q/A · filed 2017-04-07 | $11.96M 10-Q · filed 2015-08-06 | $23.08M 10-Q/A · filed 2017-04-07 | $23.59M 10-Q · filed 2015-08-06 | $36.19M derived: sum of 3 quarters · filed 2017-04-07 | $56.21M derived: sum of 4 quarters · filed 2017-04-07 | ||
| 2015-03-31 | $8.55M 10-Q/A · filed 2017-04-07 | $11.63M 10-Q · filed 2015-05-11 | $21.67M derived: sum of 2 quarters · filed 2017-04-07 | $41.69M derived: sum of 3 quarters · filed 2017-04-07 | $56.87M derived: sum of 4 quarters · filed 2017-04-07 | |||
| 2014-12-31 | $13.11M derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-03 | $33.13M derived: sum of 2 quarters · filed 2017-04-03 | $48.32M derived: sum of 3 quarters · filed 2017-04-03 | $60.99M 10-K · filed 2017-04-03 | $64.02M 10-K · filed 2015-03-03 | |||
| 2014-09-30 | $20.02M 10-Q · filed 2015-11-05 | $35.21M derived: sum of 2 quarters · filed 2015-11-05 | $47.88M 10-Q · filed 2015-11-05 | $62.29M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $15.19M 10-Q · filed 2015-08-06 | $27.86M 10-Q · filed 2015-08-06 | $42.27M derived: sum of 3 quarters · filed 2016-02-29 | $54.41M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $12.67M 10-Q · filed 2015-05-11 | $27.09M derived: sum of 2 quarters · filed 2016-02-29 | $39.22M derived: sum of 3 quarters · filed 2016-02-29 | $44.41M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $14.42M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $26.55M derived: sum of 2 quarters · filed 2016-02-29 | $31.74M derived: sum of 3 quarters · filed 2016-02-29 | $32.56M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $12.13M 10-Q · filed 2014-11-12 | $17.32M derived: sum of 2 quarters · filed 2014-11-12 | $18.14M 10-Q · filed 2014-11-12 | $9.42M derived: sum of 4 quarters · filed 2014-11-12 | ||||
| 2013-06-30 | $5.19M 10-Q · filed 2014-08-12 | $6.01M 10-Q · filed 2014-08-12 | -$2.71M derived: sum of 3 quarters · filed 2014-08-12 | -$6.19M derived: sum of 4 quarters · filed 2014-08-12 | ||||
| 2013-03-31 | $820.00K 10-Q · filed 2014-05-14 | -$7.90M derived: sum of 2 quarters · filed 2014-05-14 | -$11.38M derived: sum of 3 quarters · filed 2014-05-14 | -$16.65M derived: sum of 4 quarters · filed 2014-05-14 | ||||
| 2012-12-31 | -$8.72M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-05 | -$12.20M derived: sum of 2 quarters · filed 2014-03-05 | -$17.47M derived: sum of 3 quarters · filed 2014-03-05 | -$23.44M 10-K · filed 2014-03-05 | ||||
| 2012-09-30 | -$3.48M 10-Q · filed 2013-11-12 | -$8.75M derived: sum of 2 quarters · filed 2013-11-12 | -$14.72M 10-Q · filed 2013-11-12 | |||||
| 2012-06-30 | -$5.27M 10-Q · filed 2013-08-13 | -$11.24M 10-Q · filed 2013-08-13 | ||||||
| 2012-03-31 | -$5.97M 10-Q · filed 2013-06-05 |